Specialist
Former VP at Corteva Inc
Agenda
- EPA announcements around dicamba-based products and impacts to Corteva (NYSE: CTVA) and Bayer (ETR: BAYN)
- Recent competition between Corteva and Bayer and 2021 outlook
- Coronavirus impacts to Corteva and the agriculture industry
- US-China trade war dynamics and Corteva's innovation trends
Questions
1.
What is your high-level overview on the crop chemical and seed industry? Which current or developing trends should the investor community be monitoring?
2.
Do you have any additional commentary on where you think things are heading in the longer-term demand cycle? What are your expectations heading into 2021 – do you think commodity prices have bottomed out?
3.
What are the most topical regulatory concerns in today’s market? Could you comment about the ongoing dicamba situation and how that’s impacting individual market players?
4.
Am I right in thinking that each passing day that dicamba doesn’t achieve re-registration works in Corteva’s favour due to the uncertainty around what farmers will be able to use?
5.
Do you think the US presidential election outcome will directly impact the regulatory environment? Would you expect drastic changes overall if there were a change in administration?
6.
How are you assessing Corteva’s positioning in the marketplace and core strengths and weaknesses?
7.
Would you agree that the trait segment seems to be a longer-term play compared to everything else? How do you think that market might evolve for Corteva? What should Corteva focus on in traits?
8.
Would you say the most immediate top-line opportunities will be in crop protection?
9.
You’ve made it very clear that longer-term product development is not easy and is fairly unpredictable, to an extent. Does Corteva’s leadership team have good insight into product innovation and what is likely to yield and come to market, or are they largely dealing with unknowns here?
10.
What are the major risks around execution? Are there commonalities among competitors where execution falls to the wayside? Are there examples or common cases where you can suffer due to execution risks?
11.
Do you have any additional insights to share about the crop chemical and seed industry, or specific topics to highlight that investors tend to overlook or misunderstand?
12.
Can you talk about how Corteva’s positioning in Brazil is developing? Are you optimistic overall about Corteva gaining additional market share in Brazil? How much strategic focus was applied to the region?
13.
What strategic objectives do you think Corteva’s leadership should be focused on as we consider 2021?
Gain access to Premium Content
Submit your details to access up to 5 Forum Transcripts or to request a complimentary one week trial.
The information, material and content contained in this transcript (“Content”) is for information purposes only and does not constitute advice of any type or a trade recommendation and should not form the basis of any investment decision.This transcript has been edited by Third Bridge for ease of reading. Third Bridge Group Limited and its affiliates (together “Third Bridge”) make no representation and accept no liability for the Contentor for any errors, omissions or inaccuracies in respect of it. The views of the specialist expressed in the Content are those of the specialist and they are not endorsed by, nor do they represent the opinion of, Third Bridge. Third Bridge reserves all copyright, intellectual and other property rights in the Content. Any modification, reformatting, copying, displaying, distributing, transmitting, publishing, licensing, creating derivative works from, transferring or selling any Content is strictly prohibited